Inphi Corporation Announces First Quarter 2015 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Inphi Corporation Announces First Quarter 2015 Results

SANTA CLARA, CA--(Marketwired - Apr 28, 2015) - Inphi Corporation ( NYSE : IPHI ), a leading provider of high-speed analog and mixed-signal semiconductor solutions for the communications, data center and computing markets, today announced the financial results for its first quarter ended March 31, 2015.

Revenue in the first quarter of 2015 was $59.2 million, up 8.0% sequentially from $54.8 million reported in the fourth quarter of 2014. This was up 90% year over year compared with $31.2 million in the first quarter of 2014.

Gross margin under U.S. generally accepted accounting principles (GAAP) in the first quarter of 2015 was 50.6%, compared with 64.5% of revenue in the first quarter of 2014. The decline in gross margin was primarily due to the amortization of inventory fair value step-up related to the acquired Cortina inventories, sold during the first quarter of 2015, and amortization of the acquired intangibles.

GAAP net loss in the first quarter of 2015 was $9.7 million, or ($0.26) per diluted common share, compared with GAAP net loss of $1.0 million, or ($0.03) per diluted common share, in the first quarter of 2014.

Inphi reports revenue, gross margin, operating expenses, net income (loss), and earnings per share in accordance with GAAP and on a non-GAAP basis. A reconciliation of the GAAP to non-GAAP revenue, gross margin, operating expenses, net income, and earnings per share, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this news release.

Gross margin on a non-GAAP basis in the first quarter of 2015 was 66.6%, compared with 65.3% in the first quarter of 2014. 

Non-GAAP net income in the first quarter of 2015 was $9.3 million, or $0.23 per diluted common share. This compared with non-GAAP net income of $2.9 million, or $0.09 per diluted common share in the first quarter of 2014.

"I am pleased to report that our Q1 non-GAAP revenue and earnings per share came in at the high end of our guidance," said Ford Tamer, Inphi President and CEO. "The new technologies that we announced and demonstrated at the Optical Fiber Conference were well received. We are confident this will enable Inphi to participate in an upcoming multi-billion dollar Data Center Interconnect opportunity. In 2015, we will continue to invest for top line growth and we are committed to generating significant EPS and cash flow."

Business Outlook The following statements are based on our current expectations for the second quarter of 2015. These statements are forward-looking and actual results may differ materially.

  • Revenues are expected to be flat to up 2% sequentially for Q2 2015, resulting in a range of $59.6 million to $60.8 million.
  • Non-GAAP gross margin is expected to be approximately 68.1% - 68.6%.
  • Stock-based compensation expense is expected to be in the range of $7.0 million to $7.4 million.
  • GAAP results are expected to be in a range between a net loss of $1.0 million to $1.8 million, or ($0.03) - ($0.05) per diluted share, on approximately 38.4 million basic shares outstanding.
  • Non-GAAP net income, excluding stock-based compensation expense, is expected to be in the range of $8.9 million to $9.7 million, or $0.22 - $0.24 per diluted share, on 40.86 million estimated fully diluted shares outstanding.

Quarterly Conference Call Today Inphi will to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Ford Tamer, president and chief executive officer, and John Edmunds, chief financial officer, to discuss first quarter of 2015 results. 

The call can be accessed by dialing 844-459-2451; international callers should dial 765-507-2591, participant conference ID: 26016661. Please dial-in ten minutes prior to the scheduled conference call time. A live and archived webcast of the call will be available on Inphi's Website at http://investors.inphi.com for up to 30 days after the call.

About Inphi Inphi Corporation is a leading provider of high-speed analog and mixed-signal semiconductor solutions for the communications, data center and computing markets. Inphi's end-to-end data transport platform delivers high signal integrity at leading-edge data speeds, addressing performance and bandwidth bottlenecks in networks, from fiber to memory. Inphi's solutions minimize latency in computing environments and enable the rollout of next-generation communications infrastructure. Inphi's solutions provide a vital interface between analog signals and digital information in high-performance systems, such as telecommunications transport systems, enterprise networking equipment, enterprise and data center servers, and storage platforms. To learn more about Inphi, visit www.inphi.com .

Cautionary Note Concerning Forward-Looking Statements Statements in the press release and certain matters to be discussed on the first quarter of 2015 conference call regarding Inphi Corporation, which are not historical facts, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by terms such as outlook, believe, expect, may, will, provide, could, and should, and the negative of these terms or other similar expressions. These statements include statements relating to: our business outlook and current expectations for the second quarter of 2015, including our revenue, gross margin, operating margin, stock-based compensation expense, operating performance, net income, earnings per share; our ability to participate in an upcoming multi-billion dollar Data Center Interconnect opportunity; expectations of our growth; EPS and cash flow; success of the Cortina integration; expectations of economic trends and macroeconomic conditions; and benefits of using non-GAAP financial measures. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from those anticipated as a result of various factors, including: the Company's ability to sustain profitable operations due to its history of losses and accumulated deficit; dependence on a limited number of customers for a substantial portion of revenue and lack of long-term purchase commitments from our customers; product defects; risk related to intellectual property matters, lengthy sales cycle and competitive selection process; lengthy and expensive qualification processes; ability to develop new or enhanced products in a timely manner; development of the markets that the Company targets; market demand for the Company's products; reliance on third parties to manufacture, assemble and test products; ability to compete; and other risks inherent in fabless semiconductor businesses. In addition, actual results could differ materially due to changes in tax rates or tax benefits available, changes in claims that may or may not be asserted, as well as changes in pending litigation. For a discussion of these and other related risks, please refer to Inphi Corporation's recent SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2014, which are available on the SEC's website at www.sec.gov . Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date thereof. Inphi Corporation undertakes no obligation to update forward-looking statements for any reason, except as required by law, even as new information becomes available or other events occur in the future.

Inphi, the Inphi logo and Think fast are registered trademarks of Inphi Corporation. All other trademarks used herein are the property of their respective owners.

   
INPHI CORPORATION  
CONSOLIDATED STATEMENTS OF OPERATIONS  
(in thousands of dollars, except share and per share amounts)  
(Unaudited)  
             
    Three Months Ended March 31,  
    2015     2014  
Revenue   $ 59,160     $ 31,189  
Cost of revenue     29,238       11,063  
Gross margin     29,922       20,126  
Operating expenses:                
  Research and development     22,723       13,739  
  Sales and marketing     6,869       3,950  
  General and administrative     5,812       3,065  
Total operating expenses     35,404       20,754  
Loss from operations     (5,482 )     (628 )
Other income     168       160  
Loss before income tax     (5,314 )     (468 )
Provision for income tax     4,394       527  
Net loss   $ (9,708 )   $ (995 )
                 
Earnings per share:                
  Basic   $ (0.26 )   $ (0.03 )
  Diluted   $ (0.26 )   $ (0.03 )
                 
Weighted-average shares used in computing earnings per share:                
  Basic     37,696,518       30,697,808  
  Diluted     37,696,518       30,697,808  
                 

The following table presents details of stock-based compensation expense included in each functional line item in the consolidated statements of operations above:

         
    Three Months Ended March 31,
    2015   2014
    (in thousands of dollars)
    (Unaudited)
Cost of revenue   $ 363   $ 251
Research and development     3,786     2,389
Sales and marketing     1,025     858
General and administrative     1,246     1,008
             
    $ 6,420   $ 4,506
             
   
INPHI CORPORATION  
CONSOLIDATED BALANCE SHEETS  
(in thousands of dollars)  
(Unaudited)  
    March 31, 2015     December 31, 2014  
Assets                
Current assets:                
    Cash and cash equivalents   $ 39,542     $ 30,366  
    Short-term investments in marketable securities     38,670       38,908  
    Accounts receivable, net     36,740       36,914  
    Inventories     23,341       26,650  
    Prepaid expenses and other current assets     4,751       7,661  
      Total current assets     143,044       140,499  
                 
Property and equipment, net     34,521       35,498  
Goodwill     9,405       9,405  
Identifiable intangible assets     77,587       80,773  
Deferred tax charge and other assets     13,265       12,535  
Total assets   $ 277,822     $ 278,710  
                 
Liabilities and Stockholders' Equity                
                 
Current liabilities:                
    Accounts payable   $ 8,207     $ 7,884  
    Accrued expenses and other current liabilities     16,372       17,133  
    Deferred revenue     7,730       7,110  
      Total current liabilities     32,309       32,127  
                 
Other liabilities     9,456       7,409  
      Total liabilities     41,765       39,536  
                 
Stockholders' equity:                
  Common Stock     38       37  
  Additional paid-in capital     334,027       327,475  
  Accumulated deficit     (98,898 )     (89,190 )
  Accumulated other comprehensive income     890       852  
Total stockholders' equity     236,057       239,174  
                 
Total liabilities and stockholders' equity   $ 277,822     $ 278,710  
                 
 
INPHI CORPORATION
RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME
(in thousands of dollars, except share and per share amounts)
(Unaudited)
 

To supplement the financial data presented on a GAAP basis, the Company discloses certain non-GAAP financial measures, which exclude stock-based compensation, legal, other expenses, purchase price fair value adjustments related to Cortina acquisition and deferred tax asset valuation allowance. These non-GAAP financial measures are not in accordance with GAAP. These results should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures. The Company believes that its non-GAAP financial information provides useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations because it excludes charges or benefits that management considers to be outside of the Company's core operating results. The Company believes that the non-GAAP measures of gross margin, net income and earnings per share in combination with the Company's financial results calculated in accordance with GAAP, provide investors with additional perspective and a more meaningful understanding of the Company's ongoing operating performance. In addition, the Company's management uses these non-GAAP measures to review and assess the financial performance of the Company, to determine executive officer incentive compensation and to plan and forecast performance in future periods. The Company's non-GAAP measurements are not prepared in accordance with GAAP, and are not an alternative to GAAP financial information, and may be calculated differently than non-GAAP financial information disclosed by other companies.

   
RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME  
(in thousands of dollars, except share and per share amounts)  
(Unaudited)  
               
    Three Months Ended March 31,  
    2015       2014  
GAAP revenue to Non-GAAP revenue                
GAAP revenue   $ 59,160     $ 31,189  
Cortina revenue lost due to purchase accounting     408   (a)   -  
Non-GAAP revenue   $ 59,568     $ 31,189  
                 
GAAP gross margin to Non-GAAP gross margin                
GAAP gross margin   $ 29,922     $ 20,126  
Adjustments to GAAP gross margin:                
  Cortina revenue lost due to purchase accounting, net of cost of goods sold     303   (a)   -  
  Stock-based compensation     363   (b)   251 (b)
  Acquisition related expenses     39   (c)   -  
  Amortization of inventory step-up     6,154   (d)   -  
  Amortization of intangibles     2,875   (e)   -  
  Depreciation on step-up values of fixed assets     45   (f)   -  
Non-GAAP gross margin   $ 39,701     $ 20,377  
                 
GAAP operating expenses to Non-GAAP operating expenses                
GAAP research and development   $ 22,723     $ 13,739  
Adjustments to GAAP research and development:                
  Stock-based compensation     (3,786 ) (b)   (2,389) (b)
  Depreciation on step-up values of fixed assets     (18 ) (f)   -  
Non-GAAP research and development   $ 18,919     $ 11,350  
                 
GAAP sales and marketing   $ 6,869     $ 3,950  
Adjustments to GAAP sales and marketing:                
  Stock-based compensation     (1,025 ) (b)   (858) (b)
  Acquisition related expenses     (70 ) (c)   -  
  Amortization of intangibles     (204 ) (e)   -  
  Depreciation on step-up values of fixed assets     (12 ) (f)   -  
Non-GAAP sales and marketing   $ 5,558     $ 3,092  
                 
GAAP general and administrative   $ 5,812     $ 3,065  
Adjustments to GAAP general and administrative:                
  Stock-based compensation     (1,246 ) (b)   (1,008) (b)
  Acquisition related expenses     (456 ) (c)   -  
  Amortization of intangibles     (46 ) (e)   -  
  Depreciation on step-up values of fixed assets     4   (f)   -  
Non-GAAP general and administrative   $ 4,068     $ 2,057  
                 
Non-GAAP total operating expenses   $ 28,545     $ 16,499  
                 
GAAP net loss to Non-GAAP net income                
GAAP net loss   $ (9,708 )   $ (995)  
Adjusting items to GAAP net loss:                
  Operating expenses related to stock-based compensation expense     6,420   (b)   4,506 (b)
  Cortina revenue lost due to purchase accounting, net of cost of goods sold     303   (a)   -  
  Amortization of inventory fair value step-up     6,154   (d)   -  
  Amortization of intangibles related to purchase price     3,125   (e)   -  
  Depreciation on step-up values of fixed assets     92   (f)   -  
  Acquisition related expenses     565   (c)   -  
  Valuation allowance and tax effect of the adjustments above from GAAP to non-GAAP     2,352   (g)   (613) (g)
Non-GAAP net income   $ 9,303     $ 2,898  
                 
Shares used in computing non-GAAP basic earnings per share     37,696,518       30,697,808  
                 
Shares used in computing non-GAAP diluted earnings per share     40,325,174       32,542,808  
                 
Non-GAAP earnings per share:                
  Basic   $ 0.25     $ 0.09  
  Diluted   $ 0.23     $ 0.09  
                 
GAAP gross margin as a % of revenue     50.6 %     64.5%  
Stock-based compensation     0.6 %     0.8%  
Amortization of inventory fair value step-up and intangibles, Cortina revenue lost due to purchase accounting and others     15.4 %     -  
Non-GAAP gross margin as a % of revenue     66.6 %     65.3%  
                 
(a) Reflects the Cortina revenue lost due to purchase accounting and corresponding cost of goods sold. The Company includes this item when it evaluates the continuing operational performance of the Company.
(b) Reflects the stock-based compensation expense recorded relating to stock based awards. The Company excludes this item when it evaluates the continuing operational performance of the Company as management believes this GAAP measure is not indicative of its core operating performance.
(c) Reflects the legal, transition costs and other expenses related to Cortina acquisition. The Company excludes this item when it evaluates the continuing operational performance of the Company as management believes this GAAP measure is not indicative of its core operating performance.
(d) Reflects the cost of goods sold fair value amortization of inventory step-up related to Cortina. The Company excludes these items when it evaluates the continuing operational performance of the Company as management believes this GAAP measure is not indicative of its core operating performance
(e) Reflects the fair value amortization of intangibles related to Cortina acquisition. The Company excludes these items when it evaluates the continuing operational performance of the Company as management believes this GAAP measure is not indicative of its core operating performance.
(f) Reflects the fair value depreciation of fixed assets related to Cortina acquisition. The Company excludes these items when it evaluates the continuing operational performance of the Company as management believes this GAAP measure is not indicative of its core operating performance
(g) Reflects the change in valuation allowance and delta in interim period tax allocation from GAAP to non-GAAP related to non-GAAP adjustments. The Company excludes this item when it evaluates the continuing operational performance of the Company as management believes this GAAP measure is not indicative of its core operating performance.
   
   
INPHI CORPORATION  
RECONCILIATION OF GAAP TO NON-GAAP MEASURES -SECOND QUARTER 2015 GUIDANCE  
(in thousands of dollars, except share and per share amounts)  
(Unaudited)  
                 
      Three Months Ending June 30, 2015  
      High       Low  
Estimated GAAP net income (loss)     $ (1,000 )     $ (1,750 )
Adjusting items to estimated GAAP net income (loss):                    
  Operating expenses related to stock-based compensation expense       7,400         7,000  
 
  Amortization of inventory fair value step-up       1,900         1,900  
  Amortization of intangibles       3,220         3,220  
  Tax effect of GAAP to non-GAAP adjustments       (1,850 )       (1,500 )
Estimated non-GAAP net income     $ 9,670       $ 8,870  
                     
Shares used in computing estimated non-GAAP diluted earnings per share       40,860,000         40,860,000  
                     
Estimated non-GAAP diluted earnings per share     $ 0.24       $ 0.22  
                     

Corporate Contact: Kim Markle Inphi 408-217-7329 kmarkle@inphi.com Investor Contact: Deborah Stapleton 650-815-1239 deb@stapleton.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading